Moreover, activation of NF‐κB signaling was observed in hepatoma cells upon sorafenib treatment, despite the suppression of several other signaling pathways during this process (Figure S5F, Supporting Information). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.